Company
Granza Bio
Granza Bio utilizes the discovery of “attack particles,” a powerful suite of weapons in the immune system’s arsenal.
Also known as Granza Bio Corporation
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- San Francisco, United States
- Founded
- 2024
- Legal name
- Granza Bio Corporation
Claim, correct or request removal
Record updated 28 September 2026
About
Founded in 2024 by a team of cancer and immunology researchers at the University of Oxford, Granza Bio utilizes the discovery of "attack particles," a powerful suite of weapons in the immune system's arsenal that can fight diseases such as cancers, autoimmunity and infections.
Funding snapshot
- Total raised
- $7MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Seed, $7M2024-07-03
Funding rounds
- Seed
- $7M2024-07-03, Company stated
Loading relationship preview